FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of medicine and pharmaceuticals. First object is a rinsing liquid or liquid for insertion into the oral mucosa or a gum mucosa for the inflammation relief and/or prevention, including from 0.01 to 1.5 % (w/v) olanexidine or its pharmacologically acceptable salt, a poloxamer selected from polyoxyethylene (42) polyoxypropylene (67) glycol (Pluronic P-123), polyoxyethylene (54) polyoxypropylene (39) glycol (Pluronic P-85) and polyoxyethylene (196) polyoxypropylene (67) glycol (Pluronic F-127). Second object is using composition containing 0.01 to 1.5 % (w/v) olanexidine or its pharmacologically acceptable salt for relieving and/or preventing inflammation.
EFFECT: technical effect consists in the anti-inflammatory effect of the composition of olanexidine or a salt thereof applicable for the oral mucosa.
19 cl, 9 tbl, 12 ex, 21 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DISINFECTANT COMPOSITION | 2019 |
|
RU2805604C2 |
| SKIN DISINFECTANT COMPOSITION | 2016 |
|
RU2726981C2 |
| LIQUID PHARMACEUTICAL COMBINATION OF OCTENIDINE HYDROCHLORIDE, PHENOXYETHANOL AND NON-STEROID ANTI-INFLAMMATORY AGENT | 2021 |
|
RU2798918C2 |
| ANTISEPTIC COMPOSITION INTENDED FOR APPLICATION IN ORAL CAVITY, FOR TREATMENT OF ORAL MUCOSITIS | 2013 |
|
RU2640301C2 |
| DENTAL GEL WITH A PHYTOPELOID COMPOSITION | 2019 |
|
RU2699560C1 |
| POLYSACCHARIDE OF TAMARIND SEED FOR APPLICATION IN TREATMENT OF MICROBIAL INFECTIONS | 2011 |
|
RU2571063C2 |
| AGENT FOR TREATING ORAL CANDIDIASIS | 2021 |
|
RU2780094C1 |
| METHOD FOR SIMULATING EXPERIMENTAL RECURRENT HERPETIC STOMATITIS | 2018 |
|
RU2709842C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL CAVITY DISEASES WITH ANTI-INFLAMMATORY AND ANTI-BACTERIAL ACTIONS | 2018 |
|
RU2678821C1 |
| DOSAGE FORM FOR SUPPRESSING BACTERIAL INFECTIONS, METHOD OF ITS ORGANIZATION | 2023 |
|
RU2813197C1 |
